STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control (CE marking)
Rivaroxaban is a new oral anticoagulant, direct factor Xa inhibitor, developed by Bayer HealthCare and sold under the trade name Xarelto®. ...
For every Heparin Induced Thrombocytopenia (HIT) suspicion. A rapid and specific exclusion of Heparin Induced Thrombocytopenia in 10 minute...
The only available automated test to determine the procoagulant activity of phospholipids.
This innovating test is an indirect marker of Tissue Factor exposure In Vivo.
Stago is the market leader in the supply of Haemostasis products within the ANZ market.
Our ANZ head office and training facilities are located in Doncaster, and we have a presence in most states of Australia and both islands in New Zealand.
Our team is highly specialised, and able to support you in the field of Haemostasis.

Stago’s first mission is to provide health professionals with reliable, powerful and innovative haemostasis diagnostic tools in looking for a way to improve prevention, understanding, diagnostic, treatment and follow-up of coagulation-related pathologies.